Life Sciences: From Pilots to Scaled Production in a Year
In 2026, pharma and biotech moved from pilots to production. 43% of life sciences companies now run AI at scale, up from 12% in 2025, led by pharma at 51% (from 15%) and biotech at 35% (from 9%).
Format
JPEG
Quelle:
Menlo Ventures